Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Tumor Necrosis Factor, Type II | 15 | 2022 | 348 | 6.480 |
Why?
|
Diabetes Mellitus, Type 1 | 56 | 2023 | 3364 | 5.970 |
Why?
|
BCG Vaccine | 11 | 2023 | 358 | 4.240 |
Why?
|
T-Lymphocytes, Regulatory | 16 | 2022 | 3050 | 2.240 |
Why?
|
Spleen | 20 | 2020 | 2476 | 2.020 |
Why?
|
Autoimmune Diseases | 17 | 2021 | 2109 | 1.800 |
Why?
|
Sezary Syndrome | 3 | 2020 | 76 | 1.640 |
Why?
|
Tumor Necrosis Factor-alpha | 16 | 2018 | 4476 | 1.570 |
Why?
|
Sjogren's Syndrome | 9 | 2014 | 238 | 1.400 |
Why?
|
Cysteine Endopeptidases | 11 | 2009 | 662 | 1.360 |
Why?
|
Mice, Inbred NOD | 28 | 2014 | 1923 | 1.350 |
Why?
|
Islets of Langerhans | 22 | 2020 | 1406 | 1.340 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2020 | 614 | 1.180 |
Why?
|
C-Peptide | 5 | 2015 | 411 | 1.090 |
Why?
|
ATP-Binding Cassette Transporters | 10 | 2003 | 571 | 1.030 |
Why?
|
Autoimmunity | 12 | 2018 | 1332 | 0.980 |
Why?
|
Cell Transplantation | 5 | 2007 | 496 | 0.980 |
Why?
|
Islets of Langerhans Transplantation | 16 | 2006 | 795 | 0.960 |
Why?
|
Freund's Adjuvant | 5 | 2007 | 149 | 0.950 |
Why?
|
Gene Regulatory Networks | 2 | 2022 | 1711 | 0.930 |
Why?
|
Multienzyme Complexes | 8 | 2003 | 772 | 0.920 |
Why?
|
Histocompatibility Antigens Class I | 16 | 2002 | 1425 | 0.910 |
Why?
|
Lymphocytes | 14 | 2015 | 2748 | 0.900 |
Why?
|
Mycobacterium bovis | 1 | 2022 | 162 | 0.880 |
Why?
|
NF-kappa B | 12 | 2017 | 2579 | 0.750 |
Why?
|
Insulin-Secreting Cells | 4 | 2013 | 976 | 0.720 |
Why?
|
Antibodies, Neoplasm | 1 | 2020 | 312 | 0.720 |
Why?
|
Stem Cell Transplantation | 6 | 2010 | 1652 | 0.720 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2020 | 213 | 0.700 |
Why?
|
Homeodomain Proteins | 7 | 2010 | 2457 | 0.660 |
Why?
|
Oxidative Phosphorylation | 1 | 2020 | 489 | 0.650 |
Why?
|
Communicable Diseases | 2 | 2022 | 796 | 0.650 |
Why?
|
Genes, MHC Class II | 6 | 2003 | 505 | 0.640 |
Why?
|
Genes, MHC Class I | 5 | 1998 | 275 | 0.610 |
Why?
|
Stem Cell Niche | 2 | 2010 | 342 | 0.610 |
Why?
|
Regeneration | 7 | 2020 | 1543 | 0.600 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3071 | 0.590 |
Why?
|
Metformin | 1 | 2023 | 803 | 0.590 |
Why?
|
Blood Glucose | 11 | 2023 | 6293 | 0.580 |
Why?
|
Immunotherapy | 5 | 2022 | 4118 | 0.570 |
Why?
|
Glycolysis | 1 | 2020 | 817 | 0.570 |
Why?
|
HLA Antigens | 3 | 2015 | 1551 | 0.570 |
Why?
|
Papain | 1 | 2015 | 65 | 0.560 |
Why?
|
Central Nervous System Diseases | 1 | 2020 | 531 | 0.560 |
Why?
|
Major Histocompatibility Complex | 11 | 2003 | 1023 | 0.550 |
Why?
|
Antibodies, Monoclonal | 9 | 2018 | 9584 | 0.530 |
Why?
|
Apoptosis | 10 | 2013 | 10112 | 0.530 |
Why?
|
T-Lymphocytes | 22 | 2012 | 10379 | 0.520 |
Why?
|
Mice | 60 | 2022 | 80995 | 0.510 |
Why?
|
Cell Separation | 5 | 2011 | 1832 | 0.500 |
Why?
|
Isoantigens | 2 | 2015 | 580 | 0.500 |
Why?
|
Histocompatibility | 1 | 2015 | 362 | 0.490 |
Why?
|
Animals | 75 | 2022 | 170726 | 0.480 |
Why?
|
Immunosuppressive Agents | 3 | 2017 | 4208 | 0.470 |
Why?
|
Histocompatibility Antigens Class II | 10 | 2003 | 1539 | 0.460 |
Why?
|
beta 2-Microglobulin | 5 | 2001 | 329 | 0.460 |
Why?
|
Herpesvirus 4, Human | 5 | 2013 | 1254 | 0.450 |
Why?
|
Glutamate Decarboxylase | 2 | 2012 | 248 | 0.430 |
Why?
|
Colonic Neoplasms | 2 | 2021 | 2529 | 0.430 |
Why?
|
Antigen Presentation | 5 | 2003 | 1301 | 0.430 |
Why?
|
Graft Survival | 11 | 2001 | 3761 | 0.420 |
Why?
|
Autoantigens | 3 | 2008 | 911 | 0.420 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 713 | 0.410 |
Why?
|
Gene Expression | 7 | 2020 | 8010 | 0.410 |
Why?
|
Cell Proliferation | 5 | 2020 | 10800 | 0.410 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2094 | 0.400 |
Why?
|
Signal Transduction | 10 | 2022 | 23973 | 0.380 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2010 | 1596 | 0.360 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2003 | 1918 | 0.360 |
Why?
|
Adjuvants, Immunologic | 2 | 2021 | 977 | 0.360 |
Why?
|
Polymorphism, Genetic | 5 | 2003 | 4352 | 0.350 |
Why?
|
Insulin | 9 | 2015 | 6686 | 0.350 |
Why?
|
Proteasome Endopeptidase Complex | 10 | 2013 | 1472 | 0.350 |
Why?
|
Biological Assay | 1 | 2012 | 658 | 0.340 |
Why?
|
Proto-Oncogene Proteins | 4 | 2010 | 4688 | 0.340 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2020 | 1902 | 0.340 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4482 | 0.330 |
Why?
|
Adult Stem Cells | 1 | 2010 | 242 | 0.330 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3777 | 0.330 |
Why?
|
Humans | 86 | 2023 | 715124 | 0.330 |
Why?
|
DNA Methylation | 1 | 2021 | 4085 | 0.320 |
Why?
|
Proteins | 7 | 2002 | 6163 | 0.320 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2013 | 555 | 0.310 |
Why?
|
CpG Islands | 2 | 2021 | 1158 | 0.310 |
Why?
|
Stem Cells | 6 | 2007 | 3589 | 0.310 |
Why?
|
Splenectomy | 1 | 2007 | 406 | 0.290 |
Why?
|
Lymphocyte Subsets | 2 | 2005 | 327 | 0.290 |
Why?
|
Vaccination | 4 | 2022 | 2941 | 0.280 |
Why?
|
Organ Transplantation | 1 | 2015 | 1072 | 0.270 |
Why?
|
Immunologic Factors | 1 | 2014 | 1573 | 0.270 |
Why?
|
Prediabetic State | 6 | 2001 | 466 | 0.260 |
Why?
|
Diseases in Twins | 3 | 2003 | 463 | 0.260 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8674 | 0.240 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2007 | 672 | 0.240 |
Why?
|
Research Support as Topic | 2 | 2006 | 720 | 0.240 |
Why?
|
Neoplasms | 3 | 2022 | 20515 | 0.240 |
Why?
|
Cell Death | 2 | 2020 | 1743 | 0.240 |
Why?
|
Protein Processing, Post-Translational | 5 | 2003 | 2043 | 0.230 |
Why?
|
Disease Models, Animal | 9 | 2018 | 18345 | 0.230 |
Why?
|
Autoantibodies | 7 | 2012 | 1993 | 0.230 |
Why?
|
H-2 Antigens | 3 | 2001 | 399 | 0.230 |
Why?
|
Lymphocyte Activation | 5 | 2018 | 5897 | 0.220 |
Why?
|
Mice, Inbred BALB C | 11 | 2021 | 6677 | 0.220 |
Why?
|
HMGN1 Protein | 1 | 2021 | 28 | 0.220 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 16943 | 0.220 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2001 | 59 | 0.220 |
Why?
|
Regenerative Medicine | 1 | 2005 | 301 | 0.210 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1384 | 0.210 |
Why?
|
Antibodies | 2 | 2021 | 2445 | 0.210 |
Why?
|
Ligands | 2 | 2020 | 3332 | 0.210 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 5039 | 0.210 |
Why?
|
Brucella abortus | 1 | 2020 | 13 | 0.210 |
Why?
|
Peptides | 6 | 2005 | 4434 | 0.210 |
Why?
|
Brucellosis | 1 | 2020 | 20 | 0.200 |
Why?
|
Fetus | 1 | 2008 | 1836 | 0.200 |
Why?
|
Antibody Specificity | 2 | 2020 | 1172 | 0.200 |
Why?
|
Cell Lineage | 5 | 2010 | 2611 | 0.190 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 10980 | 0.190 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2009 | 4250 | 0.190 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2000 | 119 | 0.190 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 12425 | 0.180 |
Why?
|
Women, Working | 1 | 1999 | 84 | 0.180 |
Why?
|
B-Lymphocytes | 7 | 2013 | 4918 | 0.180 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2018 | 112 | 0.170 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2020 | 115 | 0.170 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 1468 | 0.170 |
Why?
|
Case-Control Studies | 6 | 2021 | 21790 | 0.170 |
Why?
|
Protein Isoforms | 2 | 2020 | 1709 | 0.170 |
Why?
|
Protein Stability | 1 | 2020 | 569 | 0.170 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3460 | 0.170 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 1998 | 55 | 0.160 |
Why?
|
Cells, Cultured | 8 | 2018 | 20101 | 0.160 |
Why?
|
Transplantation, Isogeneic | 2 | 1994 | 283 | 0.160 |
Why?
|
HLA-DR Antigens | 2 | 1997 | 694 | 0.160 |
Why?
|
Flow Cytometry | 7 | 2021 | 6137 | 0.160 |
Why?
|
Diabetes Mellitus | 3 | 2005 | 5415 | 0.160 |
Why?
|
Science | 1 | 1999 | 245 | 0.150 |
Why?
|
Transplantation, Heterotopic | 2 | 1994 | 182 | 0.150 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1788 | 0.150 |
Why?
|
Immunoassay | 1 | 2020 | 764 | 0.150 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1097 | 0.150 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3803 | 0.140 |
Why?
|
Adult | 17 | 2023 | 212129 | 0.140 |
Why?
|
Lymphocyte Transfusion | 2 | 1995 | 239 | 0.140 |
Why?
|
Exons | 2 | 2003 | 2476 | 0.140 |
Why?
|
Fertility | 1 | 2020 | 717 | 0.140 |
Why?
|
Insulin Antibodies | 2 | 1993 | 30 | 0.140 |
Why?
|
Raffinose | 1 | 2015 | 48 | 0.140 |
Why?
|
Leukocytes | 2 | 2000 | 2102 | 0.140 |
Why?
|
Transcription Factor RelA | 1 | 2017 | 294 | 0.140 |
Why?
|
Central Nervous System | 2 | 2018 | 1290 | 0.140 |
Why?
|
Lupus Vulgaris | 2 | 2005 | 10 | 0.140 |
Why?
|
Combined Modality Therapy | 3 | 2020 | 8912 | 0.140 |
Why?
|
Protein Conformation | 4 | 2018 | 4069 | 0.140 |
Why?
|
Mice, Inbred C57BL | 14 | 2021 | 22936 | 0.140 |
Why?
|
Organ Preservation Solutions | 1 | 2015 | 88 | 0.140 |
Why?
|
Transplantation, Heterologous | 6 | 2004 | 2436 | 0.140 |
Why?
|
Caseins | 1 | 2015 | 126 | 0.140 |
Why?
|
Membrane Glycoproteins | 2 | 2003 | 3862 | 0.140 |
Why?
|
Imidazoles | 1 | 2021 | 1270 | 0.130 |
Why?
|
Deoxyglucose | 1 | 2015 | 344 | 0.130 |
Why?
|
Cluster Analysis | 1 | 2022 | 2746 | 0.130 |
Why?
|
Hematopoietic Stem Cells | 1 | 2007 | 3450 | 0.130 |
Why?
|
Female | 33 | 2021 | 377334 | 0.130 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11192 | 0.130 |
Why?
|
Salivary Gland Diseases | 1 | 2014 | 42 | 0.130 |
Why?
|
Antigens | 1 | 2000 | 1511 | 0.130 |
Why?
|
Tumor Burden | 1 | 2020 | 1914 | 0.130 |
Why?
|
RNA, Messenger | 6 | 2013 | 13292 | 0.130 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3247 | 0.130 |
Why?
|
Submandibular Gland | 1 | 2013 | 92 | 0.120 |
Why?
|
Immunophenotyping | 1 | 2018 | 1900 | 0.120 |
Why?
|
Sialadenitis | 1 | 1993 | 44 | 0.120 |
Why?
|
Graft Rejection | 5 | 1995 | 4409 | 0.120 |
Why?
|
Allopurinol | 1 | 2015 | 202 | 0.120 |
Why?
|
Hypoglycemia | 1 | 2020 | 809 | 0.120 |
Why?
|
Antigenic Modulation | 1 | 1992 | 12 | 0.120 |
Why?
|
Alternative Splicing | 1 | 1999 | 1120 | 0.120 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2003 | 88 | 0.120 |
Why?
|
Diabetes Mellitus, Experimental | 7 | 2006 | 1231 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2021 | 1040 | 0.120 |
Why?
|
Amino Acid Sequence | 3 | 2020 | 14237 | 0.120 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 830 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 11285 | 0.120 |
Why?
|
T-Lymphocyte Subsets | 3 | 2009 | 1909 | 0.120 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2027 | 0.120 |
Why?
|
Immunoglobulin Fragments | 1 | 1992 | 93 | 0.120 |
Why?
|
Antigens, CD | 3 | 1993 | 4169 | 0.120 |
Why?
|
Drug Dosage Calculations | 1 | 2013 | 117 | 0.110 |
Why?
|
Multiple Sclerosis | 2 | 2018 | 3000 | 0.110 |
Why?
|
Glutathione | 1 | 2015 | 616 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2002 | 1484 | 0.110 |
Why?
|
Fas Ligand Protein | 2 | 2003 | 227 | 0.110 |
Why?
|
Immune Tolerance | 4 | 2018 | 2332 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3694 | 0.110 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1621 | 0.110 |
Why?
|
Cold Temperature | 1 | 2015 | 789 | 0.110 |
Why?
|
Protein Binding | 3 | 2018 | 9661 | 0.110 |
Why?
|
Gene Deletion | 2 | 1999 | 2832 | 0.100 |
Why?
|
Sex Characteristics | 1 | 2001 | 2536 | 0.100 |
Why?
|
Cell Differentiation | 5 | 2010 | 11746 | 0.100 |
Why?
|
Virus Activation | 1 | 2013 | 327 | 0.100 |
Why?
|
Substrate Specificity | 1 | 2015 | 1900 | 0.100 |
Why?
|
Isoantibodies | 3 | 1984 | 665 | 0.100 |
Why?
|
Rosette Formation | 1 | 1989 | 186 | 0.100 |
Why?
|
Receptor Cross-Talk | 1 | 2010 | 124 | 0.100 |
Why?
|
Leadership | 1 | 1999 | 1342 | 0.100 |
Why?
|
Salivary Glands, Minor | 1 | 2009 | 29 | 0.100 |
Why?
|
Ovary | 1 | 1994 | 1003 | 0.090 |
Why?
|
Histocompatibility Antigens | 1 | 1991 | 526 | 0.090 |
Why?
|
Adenosine | 1 | 2015 | 831 | 0.090 |
Why?
|
Gene Transfer Techniques | 1 | 1995 | 1285 | 0.090 |
Why?
|
Protein Subunits | 2 | 2013 | 1017 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 255 | 0.090 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2013 | 812 | 0.090 |
Why?
|
Promoter Regions, Genetic | 2 | 1997 | 6046 | 0.090 |
Why?
|
Automation | 1 | 2011 | 595 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2027 | 0.090 |
Why?
|
Research | 1 | 1997 | 2018 | 0.090 |
Why?
|
Cell Line, Transformed | 2 | 2003 | 986 | 0.090 |
Why?
|
Endoplasmic Reticulum | 3 | 2003 | 1206 | 0.090 |
Why?
|
Tissue Donors | 2 | 2001 | 2158 | 0.090 |
Why?
|
Twins, Monozygotic | 2 | 2003 | 473 | 0.090 |
Why?
|
Bone Marrow Cells | 2 | 2007 | 2592 | 0.080 |
Why?
|
Women's Health | 1 | 1997 | 1934 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 1991 | 967 | 0.080 |
Why?
|
Tuberculosis | 1 | 2020 | 1796 | 0.080 |
Why?
|
Placebos | 1 | 2012 | 1733 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 4 | 1995 | 1494 | 0.080 |
Why?
|
Male | 19 | 2020 | 351081 | 0.080 |
Why?
|
Mice, Inbred Strains | 4 | 1995 | 1917 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2021 | 8093 | 0.080 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1989 | 1019 | 0.080 |
Why?
|
Kinetics | 1 | 2015 | 6802 | 0.080 |
Why?
|
Interleukin-2 | 1 | 2013 | 1932 | 0.080 |
Why?
|
Treatment Failure | 1 | 2013 | 2678 | 0.080 |
Why?
|
Fund Raising | 1 | 2006 | 40 | 0.070 |
Why?
|
Foundations | 1 | 2006 | 101 | 0.070 |
Why?
|
Mesonephros | 1 | 2005 | 37 | 0.070 |
Why?
|
Thyroiditis, Autoimmune | 2 | 1998 | 101 | 0.070 |
Why?
|
Cell Line | 5 | 2001 | 16680 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13573 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2018 | 15260 | 0.070 |
Why?
|
Dissent and Disputes | 1 | 2006 | 144 | 0.070 |
Why?
|
Infant, Newborn | 2 | 2023 | 24645 | 0.070 |
Why?
|
Models, Biological | 2 | 2018 | 9895 | 0.070 |
Why?
|
Proteomics | 2 | 2009 | 3256 | 0.070 |
Why?
|
Tongue | 1 | 2008 | 408 | 0.070 |
Why?
|
Mass Spectrometry | 2 | 2009 | 2252 | 0.070 |
Why?
|
Graves Disease | 2 | 1998 | 249 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1992 | 2496 | 0.060 |
Why?
|
Models, Immunological | 1 | 2006 | 534 | 0.060 |
Why?
|
Middle Aged | 8 | 2020 | 214871 | 0.060 |
Why?
|
Molecular Sequence Data | 4 | 2009 | 18734 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10082 | 0.060 |
Why?
|
Ploidies | 1 | 2003 | 283 | 0.060 |
Why?
|
Base Sequence | 4 | 2002 | 13315 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19499 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2954 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6858 | 0.060 |
Why?
|
Cell Fusion | 1 | 2003 | 311 | 0.060 |
Why?
|
Transplantation, Homologous | 5 | 1995 | 4846 | 0.060 |
Why?
|
Time Factors | 5 | 2014 | 41081 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 1989 | 1487 | 0.060 |
Why?
|
Gonadal Steroid Hormones | 1 | 2006 | 687 | 0.060 |
Why?
|
Protein Biosynthesis | 2 | 2002 | 2168 | 0.060 |
Why?
|
Liver Transplantation | 1 | 1993 | 2035 | 0.060 |
Why?
|
Antibody Formation | 1 | 2006 | 1422 | 0.060 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2003 | 354 | 0.060 |
Why?
|
Mice, SCID | 1 | 2008 | 2842 | 0.060 |
Why?
|
Erythrocytes | 2 | 1989 | 2421 | 0.050 |
Why?
|
Antigen-Presenting Cells | 2 | 1997 | 984 | 0.050 |
Why?
|
Adolescent | 7 | 2015 | 84999 | 0.050 |
Why?
|
Pancreatic Ducts | 1 | 2003 | 334 | 0.050 |
Why?
|
Child | 6 | 2015 | 74146 | 0.050 |
Why?
|
Immunologic Surveillance | 1 | 2002 | 97 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5312 | 0.050 |
Why?
|
Transplantation Chimera | 1 | 2004 | 623 | 0.050 |
Why?
|
I-kappa B Proteins | 1 | 2001 | 238 | 0.050 |
Why?
|
Hearing Loss | 1 | 2008 | 711 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4375 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2004 | 2655 | 0.050 |
Why?
|
Serial Publications | 1 | 1999 | 10 | 0.050 |
Why?
|
Finland | 2 | 2002 | 604 | 0.050 |
Why?
|
Bacterial Load | 1 | 2020 | 151 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2020 | 378 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4737 | 0.050 |
Why?
|
NF-kappa B p50 Subunit | 1 | 1999 | 103 | 0.050 |
Why?
|
Skin Transplantation | 1 | 1985 | 1123 | 0.050 |
Why?
|
Cell Extracts | 1 | 1999 | 143 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 3010 | 0.050 |
Why?
|
Spain | 1 | 2020 | 462 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2005 | 3879 | 0.040 |
Why?
|
DNA Primers | 2 | 2002 | 2999 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7225 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2001 | 874 | 0.040 |
Why?
|
Young Adult | 3 | 2015 | 56155 | 0.040 |
Why?
|
Sex Factors | 2 | 2006 | 10651 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2012 | 11900 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2015 | 58505 | 0.040 |
Why?
|
Antigens, Surface | 3 | 1990 | 1851 | 0.040 |
Why?
|
Pancreas | 1 | 2005 | 1694 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2021 | 2150 | 0.040 |
Why?
|
Risk | 1 | 2009 | 9772 | 0.040 |
Why?
|
Aorta | 1 | 2005 | 2118 | 0.040 |
Why?
|
Peptide Mapping | 1 | 1997 | 271 | 0.040 |
Why?
|
Heart Atria | 1 | 1982 | 1273 | 0.040 |
Why?
|
Protein Transport | 1 | 2003 | 2065 | 0.040 |
Why?
|
Genome, Human | 2 | 2003 | 4471 | 0.040 |
Why?
|
Uterus | 1 | 2020 | 669 | 0.040 |
Why?
|
Twins | 1 | 1998 | 358 | 0.040 |
Why?
|
Murine hepatitis virus | 1 | 1995 | 19 | 0.040 |
Why?
|
Indicators and Reagents | 1 | 1997 | 482 | 0.040 |
Why?
|
Pancreatectomy | 1 | 2001 | 852 | 0.040 |
Why?
|
Phenotype | 3 | 2006 | 16371 | 0.040 |
Why?
|
Cell Division | 1 | 2004 | 4739 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1055 | 0.040 |
Why?
|
Remission Induction | 1 | 2001 | 2389 | 0.030 |
Why?
|
Nephrectomy | 1 | 2001 | 1001 | 0.030 |
Why?
|
Twin Studies as Topic | 1 | 1995 | 106 | 0.030 |
Why?
|
Protein Precursors | 1 | 1999 | 1190 | 0.030 |
Why?
|
Proteome | 1 | 2005 | 1770 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 1997 | 804 | 0.030 |
Why?
|
Self Tolerance | 1 | 1995 | 126 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 23283 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 1724 | 0.030 |
Why?
|
Mice, Nude | 1 | 2002 | 3825 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2023 | 72255 | 0.030 |
Why?
|
Reference Values | 2 | 1993 | 5061 | 0.030 |
Why?
|
Gene Frequency | 2 | 2002 | 3713 | 0.030 |
Why?
|
Prognosis | 1 | 2015 | 29168 | 0.030 |
Why?
|
Biological Transport | 1 | 1999 | 2135 | 0.030 |
Why?
|
Transfection | 1 | 2003 | 6143 | 0.030 |
Why?
|
alpha Catenin | 1 | 2013 | 43 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 1994 | 427 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 62186 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 1995 | 519 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2000 | 1850 | 0.030 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1993 | 612 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2002 | 3251 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 1995 | 637 | 0.030 |
Why?
|
Nuclear Family | 1 | 1993 | 311 | 0.030 |
Why?
|
Cell Membrane | 1 | 2003 | 3912 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 1995 | 860 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 1997 | 651 | 0.030 |
Why?
|
Aged | 3 | 2015 | 162674 | 0.030 |
Why?
|
Transcription Factors | 2 | 2013 | 12047 | 0.030 |
Why?
|
Ovariectomy | 1 | 1994 | 655 | 0.030 |
Why?
|
Aging | 2 | 2005 | 8368 | 0.030 |
Why?
|
Mutation | 3 | 2003 | 29442 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 1995 | 1951 | 0.030 |
Why?
|
Acyltransferases | 1 | 2013 | 306 | 0.030 |
Why?
|
Research Design | 1 | 2007 | 5876 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9521 | 0.030 |
Why?
|
Guinea Pigs | 1 | 1993 | 1432 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2003 | 4910 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 1994 | 9923 | 0.030 |
Why?
|
Xenopus | 1 | 1993 | 765 | 0.030 |
Why?
|
Species Specificity | 1 | 1995 | 2620 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2005 | 7947 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2013 | 724 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 4595 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1999 | 6566 | 0.020 |
Why?
|
Genetic Markers | 1 | 1997 | 2690 | 0.020 |
Why?
|
Cell Polarity | 1 | 2013 | 653 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7177 | 0.020 |
Why?
|
Morphogenesis | 1 | 2013 | 786 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 1991 | 531 | 0.020 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1991 | 505 | 0.020 |
Why?
|
Receptors, Fc | 1 | 1992 | 563 | 0.020 |
Why?
|
Cadherins | 1 | 2013 | 917 | 0.020 |
Why?
|
Boronic Acids | 1 | 2013 | 996 | 0.020 |
Why?
|
B-Lymphocyte Subsets | 1 | 2009 | 251 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1994 | 1694 | 0.020 |
Why?
|
Temperature | 1 | 1994 | 2158 | 0.020 |
Why?
|
Kidney | 2 | 1994 | 6903 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1989 | 1209 | 0.020 |
Why?
|
Alleles | 2 | 2002 | 7095 | 0.020 |
Why?
|
Muscles | 1 | 1993 | 1622 | 0.020 |
Why?
|
Lip | 1 | 2009 | 193 | 0.020 |
Why?
|
Secretory Rate | 1 | 2006 | 83 | 0.020 |
Why?
|
Salivation | 1 | 2006 | 26 | 0.020 |
Why?
|
Sheep | 1 | 1989 | 1469 | 0.020 |
Why?
|
Pyrazines | 1 | 2013 | 1269 | 0.020 |
Why?
|
Haplotypes | 1 | 1993 | 2882 | 0.020 |
Why?
|
Genotype | 2 | 2002 | 12921 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1990 | 1677 | 0.020 |
Why?
|
Peptide Fragments | 1 | 1999 | 5155 | 0.020 |
Why?
|
Outpatients | 1 | 2013 | 1366 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9022 | 0.020 |
Why?
|
Salivary Glands | 1 | 2006 | 235 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1995 | 3554 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9561 | 0.020 |
Why?
|
Genetic Testing | 1 | 1997 | 3319 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 1999 | 3950 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1989 | 1019 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3614 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1993 | 2181 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2004 | 275 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6290 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2906 | 0.010 |
Why?
|
Immune Sera | 1 | 1982 | 704 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8738 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2003 | 17395 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1993 | 2109 | 0.010 |
Why?
|
Rats, Inbred Lew | 2 | 1992 | 1174 | 0.010 |
Why?
|
Family | 1 | 1991 | 3097 | 0.010 |
Why?
|
Pilot Projects | 1 | 1992 | 8042 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 27180 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1982 | 835 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1984 | 1258 | 0.010 |
Why?
|
Immunization | 1 | 1982 | 1277 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1993 | 3677 | 0.010 |
Why?
|
Biopsy | 1 | 2009 | 6750 | 0.010 |
Why?
|
Rats | 4 | 1992 | 25090 | 0.010 |
Why?
|
Liver | 1 | 1993 | 7647 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13302 | 0.010 |
Why?
|
Dogs | 2 | 1992 | 4047 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2002 | 2066 | 0.010 |
Why?
|
Calcium | 1 | 1989 | 5818 | 0.010 |
Why?
|
Cattle | 2 | 1992 | 3998 | 0.010 |
Why?
|
Infant | 1 | 1997 | 34497 | 0.010 |
Why?
|
Child, Preschool | 1 | 1997 | 41181 | 0.010 |
Why?
|
Preoperative Care | 1 | 1982 | 2363 | 0.010 |
Why?
|
Analysis of Variance | 2 | 1992 | 6531 | 0.010 |
Why?
|
Glucuronic Acid | 1 | 1992 | 147 | 0.010 |
Why?
|
Hexuronic Acids | 1 | 1992 | 145 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 1997 | 1072 | 0.010 |
Why?
|
Swine | 2 | 1992 | 5807 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39285 | 0.010 |
Why?
|
United States | 1 | 1999 | 67665 | 0.010 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 1993 | 263 | 0.010 |
Why?
|
Alginates | 1 | 1992 | 251 | 0.010 |
Why?
|
Insulin Infusion Systems | 1 | 1992 | 219 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1992 | 397 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11766 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13732 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1991 | 1848 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4483 | 0.000 |
Why?
|
Risk Factors | 1 | 1993 | 70704 | 0.000 |
Why?
|
Concanavalin A | 1 | 1984 | 222 | 0.000 |
Why?
|
Rats, Inbred Strains | 1 | 1984 | 2268 | 0.000 |
Why?
|
Databases, Factual | 1 | 1997 | 7836 | 0.000 |
Why?
|
Glucose | 1 | 1991 | 4291 | 0.000 |
Why?
|
Immunity, Innate | 1 | 1984 | 2950 | 0.000 |
Why?
|